Hacker News new | past | comments | ask | show | jobs | submit login

Why wouldn't it? At $1300 a month, this is going to be a massive business for these companies.

I read a statement from Novo Nordisk to their investors where they said they simply underestimated demand for the drugs. They expected a slow uptake and instead received an explosive one. They are working hard to increase production.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: